TY  - JOUR
PY  - 2020//
TI  - Corrigendum: adding suicide prevention to the triple advantages of injectable long-acting second-generation antipsychotics
JO  - Frontiers in psychiatry
A1  - Pompili, Maurizio
SP  - e101
EP  - e101
VL  - 11
IS  - 
N2  - [This corrects the article DOI: 10.3389/fpsyt.2019.00931.].<br><br>Copyright © 2020 Pompili.    A Corrigendum on  Adding Suicide Prevention to the Triple Advantages of Injectable Long-Acting Second-Generation Antipsychotics    By Pompili M. Front. Psychiatry 10:931. doi: 10.3389/fpsyt.2019.00931    The author wishes to disclose that in the last two years he has lectured and served on advisory board honoraria or engaged in clinical trial activities with Angelini, Lundbeck, Janssen, Otsuka, and Allergan.    The author apologizes for this error and states that this does not change the scientific conclusions of the article in any way. The original article has been updated. <p />  <p>Language: en</p>
LA  - en
SN  - 1664-0640
UR  - http://dx.doi.org/10.3389/fpsyt.2020.00101
ID  - ref1
ER  -